Sharon H. Hrynkow, Ph.D. is Chief Scientific Officer at CTD Holdings, Inc., a Florida-based biotechnology company working to develop cyclodextrin-based drugs for the treatment of diseases with unmet medical need. Prior to joining CTD, Dr. Hrynkow served in senior leadership roles at the U.S. National Institutes of Health, including as Deputy Director and Acting Director of the John E. Fogarty International Center and as Associate Director of the National Institute on Environmental Health Sciences, and she was Senior Science Advisor at the U.S. Department of State. After 20 years of federal service, Dr. Hrynkow became the inaugural President of the non-profit organization Global Virus Network. She founded and serves as Managing Partner of Global Health Consulting, LLC. A developmental neurobiologist by training, Dr. Hrynkow has devoted her professional career to improving the health of people globally. She regularly advises organizations on health and science matters, including her current role on the NAS/NAE/NAM Division of Earth and Life Studies Advisory Committee. Dr. Hrynkow has received numerous honors during her career, including the U.S. President’s Rank Award for Meritorious Senior Executive, the King of Norway’s Order of Merit, and the AAAS “40 by 40” recognition for her work to advance science in service of society. She is an elected member of the Council on Foreign Relations and elected as a AAAS Fellow.